Non Invasive Diagnosis of Esophageal Varices

Liver cirrhosis [LC] is the final evolutive stage of any chronic liver disease and it is a condition prone to multiple complications because of portal hypertension. Development of esophageal varices [EV] is a major complication that may occur in up to 90% of cirrhotic patients. Variceal bleeding occurs in 50%-60% cirrhotic patients. Re-bleeding occurs in 7%-16%, despite endoscopic therapy. Mortality ranges between 3% and 14%. Therefore, endoscopic screening for EV in LC patients is a strong recommendation in all consensus statements. The hypothesis behind this book is to review noninvasive parameters for prediction of EV.

Autorentext

Dalia Omran is an associate Professor of Hepatology and gastroenterology at Kasr Al Ainy School of Medicine, Cairo University. She is interested in HCV and HBV related chronic liver disease, factors associated with hepatic fibrosis progression, NAFLD, and molecular pathogenesis of HCC. She has many publications in peer reviewed journals